Home
Conditions
Stage II Lung Cancer AJCC v8

Clinical trial condition

Stage II Lung Cancer AJCC v8

Explore clinical trials studying Stage II Lung Cancer AJCC v8. Study availability and eligibility vary by location and protocol.

37 public trials 14 recruiting studies

Refine in advanced search Browse all conditions

Stage II Lung Cancer AJCC v8 trial results

Recruiting

A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer

NCT06122064

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer

NCT06918132

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer

NCT05502523

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: Abington Memorial Hospital Abington, Pennsylvania, United States

Jefferson Health Northeast Philadelphia, Pennsylvania, United States

Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States

Asplundh Cancer Pavilion at Jefferson Health Willow Grove, Pennsylvania, United States

View Trial Details

Recruiting

Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer

NCT05292521

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Not Yet Recruiting

Hotspot Stereotactic Ablative Radiotherapy Versus Traditional Stereotactic Ablative Radiotherapy for the Treatment of Early-Stage Non-Small Cell Lung Cancer

NCT07718672

Conditions: Early Stage Lung Non-Small Cell Carcinoma, Lung Diseases, Lung Neoplasms, +7 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes

NCT04183218

Conditions: Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8, Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage I Esophageal Adenocarcinoma AJCC v8, +60 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

View Trial Details

Completed

Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study

NCT03634241

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
Locations: Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence

NCT04298606

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +23 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Platinum Doublet Chemotherapy and Proton Beam Radiation Therapy in Treating Patients With Stage II-III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

NCT03132532

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Completed

Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plus Standard Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC), ARCHON-1 Trial

NCT03801902

Conditions: Locally Advanced Lung Non-Small Cell Carcinoma, Locally Recurrent Lung Non-Small Cell Carcinoma, Lung Diseases, +9 more
Locations: Grady Health System Atlanta, Georgia, United States

Emory University Hospital Midtown Atlanta, Georgia, United States

Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

Emory Saint Joseph's Hospital Atlanta, Georgia, United States

View all 56 locations

View Trial Details

Stage II Lung Cancer AJCC v8

Stage II Lung Cancer AJCC v8 trial results

Related conditions